The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in mycocis fungoides/sézary syndrome cells

Journal of Investigative Dermatology

Volumn 123, Issue 2, 2004, Pages 380-387

  Zhang, Chunlei ^a   Ni, Xiao ^a   Konopleva, Marina ^a   Andreeff, Michael ^a   Duvic, Madeleine ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

bcl xL; Mycosis fungoides; PPAR ; RXR; S zary syndrome

Indexed keywords

2 CYANO 3 (12 DIOXOOLEAN) 1,9 DIEN 28 OIC ACID; BEXAROTENE; CASPASE 3; CD4 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; DRUG VEHICLE; HORMONE RECEPTOR BLOCKING AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; PROTEIN BCL 2; PROTEIN BCL XL; RETINOID X RECEPTOR; ROSIGLITAZONE; T 007; TRITERPENOID; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL ISOLATION; CELL LINE; CIRCULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG SCREENING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MYCOSIS FUNGOIDES; PATIENT; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEZARY SYNDROME; T LYMPHOCYTE; TIME;

EID: 3242735499     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.23207.x     Document Type: Article

References (53)

1. Apisarnthanarax N, Duvic M: Therapy options in cutaneous T-cell lymphoma. Expert Rev Anticancer Ther 1:403-420, 2001
2. Bladon J, Taylor PC: Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients. Brit J Haematol 107:707-711, 1999
3. Dereure O, Portales P, Clot J, Guilhou JJ: Decreased expression of Fas (APO-1/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T-cell lymphomas. Br J Dermatol 143:1205-1210, 2000
4. Dummer R, Michie SA, Kell D, et al: Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates. J Cutan Pathol 22:11-17, 1995
5. Duriez PJ, Shah G: Cleavage of poly (ADP-ribose) polymerase: A sensitive parameter to study cell death. Biochem Cell Biol 75:337-349, 1997
6. Duvic M, Cather JC: Emerging new therapies for cutaneous T-cell lymphoma. Dermatol Clin 18:147-156, 2000
7. Duvic M, Hymes K, Heald P, et al: Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: Multinational phase II-III trial results. J Clin Oncol 19:2456-2471, 2001
8. Duvic M, Martin AG, Kim Y, et al: Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch Dermatol 137:581-593, 2001
9. Forman BM, Chen J, Evans RM: Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 94:4312-4317, 1997
10. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM: 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83:803-812, 1995
11. Goodwin CJ, Hoil SJ, Downes S, Marshall NJ: Microculture tetrazolium assays: A comparison between two new tetrazolium salts, XTT and MTS. J Immunol Methods 179:95-103, 1995
12. Gootenberg JE, Ruscetti FW, Mier JW, Gazdar A, Gallo RC: Human CTCL and leukemia cell lines produce and respond to T cell growth factor. J Exp Med 154:1403-1418, 1981
13. Hickman JA: Apoptosis induced by anticancer drugs. Cancer Metast Rev 11:121-139, 1992
14. Honda T, Gribble GW, Suh N, et al: Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages. J Med Chem 43:1866-1877, 2000
15. Ito Y, Pandey P, Place A, et al: The novel triterpenoid 2-cyano-3,12-dioxoolean-1, 9-dien-28-oic acid induces apoptosis of human myeloid leukemia cells by a caspase-8-dependent mechanism. Cell Growth Differ 11:261-267, 2000
16. Ito Y, Pandey P, Sporn MB, Datta R, Kharbanda S, Kufe D: The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism. Mol Pharmacol 59:1094-1099, 2001
17. Kacinski BM, Flick M: Apoptosis and cutaneous T cell lymphoma. Ann NY Acad Sci 941:194-199, 2001
18. Kanavaros P, Ioannidou D, Tzardi M, et al: Mycosis fungoides: Expression of c-myc p62, p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus. Pathol Res Pract 190:767-774, 1994
19. Kerr JF, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Brit J Cancer 26:239-257, 1972
20. Kodera Y, Takeyama K, Murayama A, et al: Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators. J Biol Chem 275:33201-33204, 2000
21. Lapillonne H, Konopleva M, Tsao T, et al: Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3, 12-dioxooleana-1, 9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells. Cancer Res 63:5926-5939, 2003
22. Lee G, Elwood F, McNally J, et al: T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities. J Biol Chem 277:19649-19657, 2002
23. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270:12953-12956, 1995
24. Mangelsdorf DJ, Evans RM: The RXR heterodimers and orphan receptors. Cell 83:841-850, 1995
25. Mangelsdorf DJ, Thummel C, Beato M, et al: The nuclear receptor superfamily: The second decade. Cell 83:835-839, 1995
26. Meech SJ, Edelson R, Walsh P, Norris DA, Duke RC: Reversible resistance to apoptosis in cutaneous T cell lymphoma. Ann NY Acad Sci 941:46-58, 2001
27. Mukherjee R, Davies PJ, Crombie DL, et al: Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386:407-410, 1997
28. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279, 1991
29. Nolte RT, Wisely GB, Westin S, et al: Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395:137-143, 1998
30. Nunez G, Benedict MA, Hu Y, Inohara N: Caspases: The proteases of the apoptotic pathway. Oncogene 17:3237-3245, 1998
31. Osella-Aate S, Zaccagna A, Savoia P, Quaglino P, Salomone B, Bernengo MG: Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy. J Am Acad Dermatol 44:40-47, 2001
32. Pedersen IM, Kitada S, Schimmer A, et al: The triterpenoid CDDO induces apoptosis in refractory CLL B cells. Blood 100:2965-2972, 2002
33. Popovic M, Sarin PS, Robert-Gurroff M: Isolation and transmission of human retrovirus (HTLV). Science 219:856-859, 1983
34. Reed JC: Bcl-2 family proteins. Oncogene 17:3225-3236, 1998
35. Siegel RS, Pandolfino T, Guitart J, Rosen S, Kuzel TM: Primary cutaneous T-cell lymphoma: Review and current concepts. J Clin Oncol 18:2908-2925, 2000
36. Stadheim TA, Suh N, Ganju N, Sporn M, Eastman A: The novel triterpenoid 2-cyano-3, 12-dioxooleana-1, 9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells. J Biol Chem 277:16448-16455, 2002
37. Starkebaum G, Loughran TP, Waters CA, Ruscetti FW: Establishment of an IL-2 independent human T-cell line possessing only the p70 IL-2 receptor. Int J Cancer 49:246-253, 1991
38. Suh N, Honda T, Finlay HJ, et al: Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res 58:717-723, 1998
39. Suh N, Roberts AB, Birkey Reffey S, et al: Synthetic triterpenoids enhance transforming growth factor β/Smad signaling. Cancer Res 63:1371-1376, 2003
40. Suh N, Wang Y, Honda T, et al: A novel synthetic oleanane triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. Cancer Res 15:336-341, 1999
41. Synderman CH: Apoptosis and its clinical impact. Head and Neck 23:409-425, 2001
42. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM: PPAR gamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93:241-252, 1998
43. Tsao T, Konopleva M, Sporn MB, Andreeff M: Targeted induction of apoptosis in leukemias by PPAR gamma ligation. Blood 98:568a, 2001
44. Varadachary AS, Salgame P: CD95 mediated Tcell apoptosis and its relevance to immune deviation. Oncogene 17:3271-3276, 1998
45. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V. J Immunol Methods 184:39-51, 1995
46. Wang Y, Porter WW, Suh N, et al: A synthetic triterpenoid, 2-cyano-3, 12-dioxooleana-1, 9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma. Mol Endocrinol 14:1550-1556, 2000
47. Webb SJ, Harrison DJ, Wyllie AH: Apoptosis: An overview of the process and its relevance in disease. Adv Pharmacol 41:1-34, 1997
48. Westin S, Kurokawa R, Nolte RT, et al: Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature 395:199-202, 1998
49. Yang Y, Liu X, Bahalla K, et al: Prevention of apoptosis by bcl-2: Release of cytochrome c from mitochondria blocked. Science 275:1129-1131, 1997
50. Yoo EK, Rook AH, Elenitsas R, Gasparro FP, Vowels BR: Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: Relevance to mechanism of therapeutic action. J Invest Dermatol 107:235-242, 1996
51. Zhang CL, Hazarika P, Ni X, Weidner DA, Duvic M: Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: Relevance to mechanism of therapeutic action. Clin Cancer Res 8:1234-1240, 2002
52. Zhang CL, Kamarashev J, Qin JZ, Burg G, Dummer R, Döbbeling U: Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells. J Pathol 200:249-254, 2003
53. Zoi-Toli O, Vermeer MH, De Vries D, Van Beek P, Meijer CJLM, Willemze R: Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): Association between lack of Fas expression and aggressive types of CTCL. Br J Dermatol 143:313-319, 2000